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Microiontophoresis and Related Methods
Synonyms
Iontophoresis
Definition
The term microiontophoresis is derived from the ancient Greek term phoretikos, which
refers to the production or induction of movement. Microiontophoresis is a technique with
which drugs and other ionized particles can be ejected in very small amounts from solutions
contained in glass micropipettes. This ejection is accomplished by applying a voltage
across the micropipette and causing the electrode to become polarized. Ionized particles in
solution migrate in the applied field and will be ejected from the tip as they carry the
current into the tissue. This technique is widely used to determine the effects of various
substances on firing parameters of both central and peripheral neurons and muscles. In
investigating the phenomenon of synaptic transmission at the neuromuscular junction,
during the 1950s, this technique became very popular. A technique appropriate for the
study of synaptic pharmacology was first realized by Nastuk (1953) and was later
developed by del Castillo and Katz (1955), and it consisted essentially of the
microiontophoretic method, i.e., movement of charged particles produced by an electric
current, restricted to a micropipette with a tip diameter of the order of 1 μm. Thus,
solutions of acetylcholine chloride were used, and by passing a suitable current to this
solution, acetylcholine ions could be ejected from the 1 μm orifice onto a correspondingly
localized area of subsynaptic membrane at the neuromuscular junction. Later, Curtis and
his colleagues adopted this technique for studying the mammalian central nervous system
(CNS) (Curtis and Eccles 1958b). The experiments of Curtis and coworkers, however,
involved an important modification of the original method, in that this group used
multibarrel micropipettes. In the production of these, several lengths of tubing are fused
together and then pulled so as to produce a single collective tip, but with each barrel
having its own orifice. Multibarrel micropipettes are usually composed of five to seven
barrels (Fig. 1). Usually, the central barrel is the recording electrode, whereas the other
side barrels contain drug solutions (Fig. 1). As the drug molecules would tend to diffuse
from solution in the pipette tip into the extracellular environment, it is necessary to apply a
small current to reduce that efflux. This is known as a "holding" or "retaining" current (Fig.
2). It is also a usual practice to include a barrel containing sodium chloride solution, which
can be used to control the effects of the current itself. This may be done either by
periodically passing through the control barrel the same current used for drug ejection or
by passing continuously a current adequate to cancel out the instantaneous sum of
ejecting and retaining currents passing through the drug-containing barrels. This is known
as "current balancing." The use of microiontophoresis is suitable for any ionized molecule,
but nonionized compounds can be ejected by the closely related variant "electro-osmosis,"
which is attributable to the presence of an electrical "double layer" within the barrel tip.
When an aqueous solution is in contact with glass, negative ions are tightly adsorbed on
the glass surface, leaving the bulk of solution carrying a net positive charge. The passage
of positive (or outward) current then causes the ejection of a small volume of solution
containing the compound of interest (Fig. 2). It should be noted, however, that this
mechanism has nothing to do with the osmotic pressure of a solution or the establishment
of any osmotic gradient. The term electro-osmosis derives simply from the fact that the
driving force is the movement of the solvent, not the solute, just as the case of osmotic
movements across a semipermeable membrane. An alternative method of applying both
ionized and nonionized compounds from micropipettes is the use of pressure. A suitable
source of pressure, usually a cylinder of compressed gas, is connected to the open end of
a micropipette barrel. Pressure usually up to 20 pounds per square inch (p.s.i.) will eject
fluid from a 1 μm pipette tip. One advantage of micropressure ejection is that it can be
applicable to all compounds; however, it is not devoid of problems and artifacts and is
unlikely to replace microiontophoresis as a microapplication method.
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Microiontophoresis and Related Methods. Fig. 1. Examples of different types of
multibarrel micropipette assemblies used in microiontophoretic experiments. (a)
Standard 7-barrel assembly in most common use, introduced first by Curtis. (b)
Twin, or parallel micropipette. (c) Co-axial assembly. (d) Staggered tip multibarrel.
(From Hicks, 1984.)
Microiontophoresis and Related Methods. Fig. 2. Schematic diagram of a micropipette
that contains a salt X+Y−, showing the direction of current necessary to eject (a)
and retain (b) the ion X+. (From Hicks, 1984.)
Principles and Role in Psychopharmacology
General Principles
Each barrel of a micropipette assembly to be used for drug ejection is filled with a solution
of the ionized compound and the solution is connected to the iontophoresis machine by a
suitable lead, which is in contact with the drug solutions. The establishment of a potential
difference between the drug solution and the medium surrounding the barrel tip will then
cause the movement of ions through the solution and out of the pipette tip (Fig. 2). A
chief advantage of the microiontophoretic method is that it is possible to examine the
effects of drugs on single neurons in vivo without affecting the whole nervous system or
other physiological responses, such as those that may occur when drugs are administered
systemically (Aghajanian 1972). If a voltage is applied to a solution, ions and charged
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molecules will migrate toward and away from the source of the imposed electrical field
depending on the sign of their net charge. This phenomenon is the fundamental principle of
microiontophoresis: the desired charged particles are ejected from the mouth of one barrel
of a multipipette assembly by appropriately charging the interior of that barrel (Fig. 2). An
outward current will cause the "ejection" of positively charged ions, and an inward current
flow, the ejection of negatively charged particles. If the pipette assembly is positioned
close to a neuron, so that the recordings of its activity can be made through another
electrolyte-filled barrel, drugs may be ejected and their pharmacological effects are
inferred by the resulting changes in the rate and/or firing pattern.
The Transport Number and the T 50 Value
An important technical consideration for experiments employing microiontophoresis is the
transport number. The transport number is a measure of the amount of drug released from
the micropipette by iontophoretic expulsion and it is important, because it helps one to
evaluate dose-response relations between different compounds, and it can also provide
some indication of the absolute potency of compounds. The transport number varies for
individual compounds and is based on the interaction of the following variables: their
solubility, the extent of their dissociation in solution, their polarity, and the nature of the
external medium into which the drugs are administered. The transport number may be
formally described by the following equation:
n = R i ZFi 
-1 , where
n = apparent transport number of the drug ion,
Z = valency,
F = Faraday's constant, in Coulombs
i = intensity of ejecting current, in nanoamperes, and
R i = rate of microiontophoretic release (which is equivalent to total release minus the sum
of the rate of steady-state spontaneous release and where applicable, the release due to
electro-osmosis).
During microiontophoresis, the total number of ions transported is related in a direct
manner to the amount of current applied to the solution, according to Faraday's law.
However, only a certain proportion of the charge imposed is carried by the ion species of
interest. This value, which is "n," the transport number, is not constant for a given material
but will vary not only from pipette to pipette, but also, to a lesser extent, between
different barrels of the same micropipette assembly containing identical solutions. Despite
these inconsistencies, it remains valid that under steady-state conditions, drug release
from micropipettes conforms to Faraday's law: the amount of drug released is proportional
to the magnitude of current passed (Hicks 1984).
Another important parameter to consider when interpreting microiontophoretic data is the T
50 value, which is the time taken for a response to reach 50% of its maximum (Fig. 3). The
basis for this procedure is the hypothesis that each individual response to an agonist may
be considered as a cumulative dose-response relationship reflecting the gradual increase in
tissue concentration of drug during the ejection period. If a series of such responses are
obtained, reaching the same maximum amplitude, they can be readily characterized by the
T 50 value (Fig. 3). Moreover, T 50 value is easier to measure accurately than a response
size. Thus, it can be very difficult to obtain reproducible graded response amplitudes to
some very potent compounds such as amino acids. Any changes in firing rate during a
response, which ideally should be of the plateau variety, may further complicate any
assessment of the response size, whereas in the determination of T 50 values, all
responses increase to the same maximal level, which may be 100% inhibition or a clear
maximal plateau of excitation tending toward overdepolarization.
Microiontophoresis and Related Methods. Fig. 3. Time courses of inhibition of
neuronal firing following microiontophoretic application of GABA with four different
currents, 20 nA (filled circle), 10 nA (o), 5 nA (×), and 2 nA (open triangle). Each
curve was obtained from the same neuron at a depth of 957 μm in the middle
suprasylvian gyrus of the cat cortex. The neuron was driven by continuous
microiontophoretic application of L-glutamate (20 nA). Each of the points for 20, 10,
and 5 nA applications of GABA is the mean ± SEM of three values obtained from
three separate applications of the same current of GABA. The values of T50 shown
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are the times taken to achieve 50% inhibition of neuronal firing. (From Hill and
Simmonds (1973) Br J Pharmacol 48:1-11.)
Microiontophoresis in the Central Nervous System
It is now more than 50 years since Curtis and Eccles (1958a, b) first employed the
technique of microiontophoresis in the CNS. Microiontophoresis has provided so far a great
contribution in the identification of the central effects of neurotransmitters, including
glutamate, aspartate, γ-aminobutyric acid (GABA), noradrenaline, serotonin, dopamine, and
a variety of neuropeptides (enkephalins, cholecystokinin, neurotensin, tachykinins).
Microiontophoresis also allows the histological confirmation of the sites of
electrophysiological recordings, and the neuroanatomical determination of pathways by
applying dyes, markers, and materials, which are carried by axonal transport for tracing
fiber tracts. Alterations in neuronal sensitivity due to the influence of anesthetic
compounds have been monitored when pharmacological agonists have been tested using
microiontophoresis.
Applications
The largest number of studies has been concerned with the central nervous system. These
studies have yielded information on: (1) the qualitative sensitivity of neurons to putative
neurotransmitters and drugs; (2) quantitative estimates of variations and sensitivity in
different CNS regions or of different cell types and the following lesions or the
administration of drugs; (3) the pharmacology of transmitter receptors; (4) the effects of
modifier of putative transmitter effects (antagonistic or enhancing substances) on synaptic
transmission; and (5) the mechanisms and ionic conductances underlying transmitters
effects.
Excitatory Amino Acids
Some of the earliest iontophoretic studies demonstrated marked excitatory activity of
several simple dicarboxylic acids, including L-glutamic and L-aspartic acids (Curtis and
Watkins 1960). Responses to some of these amino acids, especially glutamate and
aspartate, terminate rapidly when an ejecting iontophoretic current is switched off. It is
unclear to what extent this is due to the kinetics of iontophoresis or reflects the presence
of rapid and efficient uptake processes. Some authors have reported long-lasting changes
of cortical neuronal firing following iontophoresis of glutamate sufficient to at least double
the resting firing rate. The development of a series of potent amino acids analogs with very
high agonist potency led to the discovery of NMDA and non-NMDA glutamate receptors.
This discovery was strengthened by additional findings that phosphonate analogs of amino
acids, such as 2-amino-5-phosphonovaleric acid (AP-5) blocked the effects of NMDA, but
not of quisqualic and kainic acids.
Inhibitory Amino Acids
Both glycine and GABA act as potent inhibitors of neuronal activity in the CNS, usually
causing hyperpolarization associated with increased membrane conductance to chloride.
Glycine is selectively antagonized by strychnine, whereas the effects of GABA are blocked
by picrotoxin and bicuculline. Microiontophoretic experiments showing potentiation of the
inhibitory effects of GABA by benzodiazepines were among the earlier experimental
evidence for the modulatory action of these drugs on GABAA receptors (Gallagher 1978).
Acetylcholine
Almost every region of the brain has been examined for its sensitivity to iontophoretically
applied cholinergic agents. Most of the earlier work in vivo was concerned primarily with
establishing the direction of responses to cholinomimetics and whether the effects involved
muscarinic or nicotinic receptors. Many studies examined only cells encountered randomly
in a particular brain region, but others have often succeeded in relating the direction of
responses to cholinomimetics with some specific function. In the cerebral cortex deep
pyramidal tract, cells are excited by acetylcholine. Several authors have also described an
inhibitory action of acetylcholine, largely muscarinic in nature, in more superficial levels of
the cortex and an excitatory action, which appears to have a predominant nicotinic
pharmacology, in the same superficial layers. Some authors have shown that acetylcholine
enhances the stimulus-evoked responses of visually driven cortical units, without affecting
the overall excitability of the cell. Thus, orientation and direction specificity of neurons is
preserved and increased relative to the nonpreferred responses. This phenomenon is
reminiscent of the effects of some amines, which can also increase the signal-to-noise
ratio by potentiating evoked activity and suppressing background.
Noradrenaline
Early microiontophoretic studies have shown that noradrenaline would cause a depression
of neuronal firing in the cat cerebral cortex, and a large number of experiments have
revealed similar responses in most areas of the CNS. This inhibition often seems to involve
a voltage-dependent hyperpolarization accompanied by an increased membrane resistance,
although a decreased membrane resistance was found on neurons of the locus coeruleus in
slice preparation in vitro. The biochemical basis of this hyperpolarization has been the
subject of much argument. Although it was originally suggested that they may be mediated
by an increase in the intracellular concentration of cyclic AMP, some group failed to
reproduce these findings. Overt excitatory effects of noradrenaline have also been
observed in many areas of the CNS. Neuronal responses to iontophoretic application of
noradrenaline, apparently excitatory as well as inhibitory, can be enhanced by
antidepressants. However, this potentiation can occur even after the loss of most amine-
containing terminals, and it may be restricted to certain layers of the cortex. The
pharmacology of responses to iontophoretically applied noradrenaline has been extensively
studied. Some authors have postulated that, in the neocortex, excitatory responses to
noradrenaline are mediated by α1-adrenergic receptors, whereas inhibitory responses occur
through β-adrenergic receptors. Activation of α2-adrenergic receptors does also elicit
inhibitory responses.
Dopamine
Dopamine was first tested iontophoretically in the cerebral cortex, where profound
suppression of spontaneous cell firing was observed. This action has been confirmed by
several authors, although excitatory effects have also been reported. Much attention has
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been centered on the effects of dopamine in the neostriatum where its action is usually
inhibitory in the caudate nucleus. Bunney and Aghajanian (1976) have performed a laminar
analysis of amine responses in the rat cerebral cortex. They found that neurons in layers II
and III, which receive a dense noradrenergic projection, were more sensitive to
noradrenaline than dopamine, whereas the reverse pattern was noted in layers V and VI,
which receive a greater dopamine-containing projection. These authors also reported that
desipramine, a selective inhibitor of noradrenaline reuptake, would enhance noradrenaline
responses in layers II and III, but not in deeper layers, while benztropine enhanced
dopamine responses only in layers V and VI. Dopamine receptors are present not only on
innervated cells but also on the dopaminergic neurons themselves: the so-called
autoreceptors. Activation of such receptors by dopamine or apomorphine causes marked
inhibition of cell firing, and these effects are blocked by neuroleptic drugs.
Microiontophoretic studies of dopamine response pharmacology have mostly proved
consistent with behavioral and neurochemical work. Phenothiazines, for example, block
dopamine but not noradrenaline responses in the cerebral cortex and the striatum.
Iontophoretically applied α-flupenthixol can also block the effects of dopamine, although
intravenously administered α-flupenthixol or pimozide did not modify neuronal responses to
iontophoretic dopamine.
Serotonin
There is an extensive scientific literature regarding the effects of microiontophoretically
applied serotonin on different areas of the central nervous system. Indeed, the
microiontophoretic technique contributed substantially to the elucidation of the physiology
and pharmacology of the central serotonergic system. Thus, an important factor controlling
the activity of central serotonergic neurons is neuronal feedback inhibition. This is thought
to be a homeostatic response, which, under physiological conditions, acts to compensate
for increases in synaptic availability of serotonin. Thus, as the concentration of serotonin
increases in the brain, the activity of central serotonergic neurons correspondingly
decreases. The mechanism underlying this feedback regulation is both local or intrinsic to
the raphe region (where serotonergic cell bodies are located) and through a feedback loop
from postsynaptic target neurons. Serotonin released in the raphe region from dendrites
and possibly from axon terminals appears to inhibit serotonergic neurons by activating
somatodendritic autoreceptors, which produces hyperpolarization of the cell membrane via
an increase in potassium conductance. Historically, the first drug reported to exert a
preferential action on the 5-HT autoreceptor was LSD (lysergic acid diethylamide) applied
microiontophoretically on the dorsal raphe nucleus of rats. Subsequently, several other
hallucinogenic indoleamines, notably 5-MeODMT (5-methoxy-N,N-dimethyltryptamine), were
found to share this property with LSD. Since that time, several highly selective 5-HT1A
agonist compounds such as 8-OH-DPAT have been synthesized and shown to suppress the
firing of serotonergic neurons with potencies comparable with, or even greater than, that
of LSD. On the basis of electrophysiological data, the serotonin autoreceptor has been
characterized as the 5-HT1A subtype. Microiontophoretic technique also contributed to
characterize the action of serotonin agonists and antagonists and to elucidate the
physiological role of serotonin receptor subtypes such as 5-HT1B, 5-HT2A, and 5-HT2C. As
regards the 5-HT2C, it was found that this receptor subtype exerts a tonic inhibitory
influence on the activity of dopamine-containing neurons in the substantia nigra pars
compacta and the ventral tegmental area. Apparently, this inhibitory effect is mediated
through the activation of nondopaminergic (presumably GABA-ergic) neurons in the
substantia nigra pars reticulata. Thus, it was recently shown that microiontophoretic
application of 5-HT2C receptor agonists stimulates the basal activity of nondopaminergic
(presumably GABA-ergic) neurons in the substantia nigra pars reticulata (Invernizzi et al.
2007) (Fig. 4). By using microiontophoresis, it was also found that serotonin exerts a tonic
inhibitory influence on the activity of noradrenergic neurons in the locus coeruleus.
Microiontophoresis and Related Methods. Fig. 4. Representative rate histogram
showing the effect of the selective 5-HT2C receptor agonist RO 60-0175 on the
basal activity of a nondopaminergic (presumably GABA-ergic neuron) of the rat
substantia nigra pars reticulata. Microiontophoretic application of RO 60175 causes
excitation of basal neuronal activity, which is proportional to the amount of the
ejecting current applied (numbers above each bar in nA). (From Invernizzi et al.
2007.)
Opiates and Opioids
Microiontophoresis has proved exceedingly valuable for opiate system studies, since it
allows the testing of discrete units activated by noxious or nonnoxious stimuli in the same
preparation. In most such studies, the applied opiates have depressed noxious stimulus-
evoked activity, although usually in parallel with the effects on spontaneous or chemically
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induced firing. Microiontophoresis has also been proved as a popular means for comparing
qualitatively opiate responses in normal and opiate-tolerant animals. Thus, inhibitory
responses to morphine were encountered less frequently in the neocortex of morphine-
tolerant rats than in controls. It was shown that iontophoretically applied naloxone would
elicit a large increase of firing in the locus coeruleus noradrenergic neurons in morphine-
tolerant rats, presumably as a correlate of the withdrawal phenomenon in such animals.
Also, opioid peptides have been tested iontophoretically in many regions of the central
nervous system. Opioid peptides were found to excite hippocampal neurons; however,
these effects were apparently mediated through an indirect action on transmitter release
or to a naloxone-sensitive depression of local inhibitory interneurons.
Peptides
Microiontophoretic or pressure ejection has been used to apply a wide range of
endogenous and synthetic peptides to neurons in vivo and in vitro. However, partly
because of the lack of selective antagonists, there has been little progress in relating the
observed responses to a physiological role, and as a result, attention has been
concentrated on the mechanism of the observed responses, and potential interactions with
neurotransmitters. Substance P, for example, appears to interact selectively with
acetylcholine. Microiontophoretic substance P has also been found to enhance the
response of spinal cord neurons to noxious stimulation but not innocuous ones, in some
cases leading to the occurrence of responses in initially unresponsive units. Some
excitatory effects of substance P can be mimicked by capsaicin, also applied
iontophoretically. It was also reported that the excitatory effect of substance P on
noradrenalin-containing neurons in the locus coeruleus is blocked by the selective
antagonist [D-Pro2, D-Trp7,9] substance P. Thyrotropin releasing hormone (TRH) has been
found to enhance the excitatory effects of acetylcholine on cortical neurons, with no
effects on resting firing rate. Somatostatin exerts a potent excitatory effect on
hippocampal neurons. Cholecystokinin (CCK) and neurotensin are also frequently excitatory
while angiotensin has excitant properties, which appear to be restricted to the subfornical
organ and related structures. However, it is important to point out that peptides present
special problems for microiontophoresis. Larger molecules tend to be adsorbed on to
charged surfaces, which include the internal wall of a micropipette tip. Some peptides may
also undergo denaturation or degradation during iontophoretic experiments. This problem
may be exacerbated if very high currents are applied for long periods of time through high
resistance tips, in that any change of local temperature may have a major impact on the
stability of a peptide.
Advantages and Disadvantages of Microiontophoresis
The original microiontophoretic technique was developed for answering questions
concerned with synaptic transmission and the neuromuscular junction. Using this
preparation, it is a simple matter to microscopically examine the muscle fiber being studied,
to determine the distance of the micropipette from the tissue, and to have ready access
to known synaptic inputs. These advantages are not valid for the CNS. Nevertheless, with
some further precautions and considerations, the technique has been used successfully in
the CNS for about 50 years. It is important to consider other potentially confounding
technical factors limiting the utility of microiontophoresis, as it is used in central
investigations. Of primary concern is the site of drug administration relative to cell soma,
where the strongest depolarizing or hyperpolarizing influences are manifested, and the
dendritic field, where synaptic influences are normally expressed and where antagonists of
transmitters must accumulate to modify trans-synaptic excitations. Another consideration
for central investigations also concerns the spatial distribution of drugs in the CNS. Since
the CNS is densely packed with cells, microiontophoretically administered compounds
cannot affect single neurons in isolation. This must be kept in mind when interpreting the
data.
Conclusions
Microiontophoresis, an experimental technique introduced more than 50 years ago,
prompted a great impetus to the study of the physiology and pharmacology of the central
nervous system. By mimicking the synaptic function, it provided a crucial step in
establishing the physiological role of most neurotransmitters, including amines, amino acids,
and neuropeptides. Although it is now considered by some as a "classical" neurophysiologic
approach to the study of central nervous system, it is likely that it will still contribute
substantially to the progress of neuroscience.
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